Study identifies biomarker for breast cancer response to immunotherapy
A biomarker that has proven to be a predictor for response to immunotherapies in melanoma patients also has clinical relevance for breast cancer patients, according […]
Home »
A minimally invasive blood test along with artificial intelligence (AI) may flag early-stage Alzheimer’s disease (AD), raising the prospect of early intervention when effective treatments […] Low blood levels of immune cells called lymphocytes, in combination with higher levels of inflammation on PET/CT scans, are indicators of active sarcoidosis — an […] Mass spectrometry (MS) is a powerful method for biomarker analysis because it enables highly sensitive and accurate measurement of target molecules in clinical samples. The […] Specific angles and sharpness of brain waves seen in unfiltered raw data from scalp electroencephalograms have been tied to Parkinson’s disease. Reporting in the online […] The promise and challenges of liquid biopsy, an emerging, noninvasive method for targeted disease diagnosis and detection of cancer biomarkers to enable improved and personalized […] Starting heart failure patients on the compound sacubitril/valsartan instead of enalapril after they’ve been discharged from the hospital led to an improvement in biomarkers of […] A team of researchers from the Netherlands, the U.S. and the U.K. has found evidence that suggests tumor necrosis factor (TNF) cannot be used as […]
Simple Blood Test Plus AI May Flag Early Stage Alzheimer’s
New biomarker discovery could help guide treatment of active sarcoidosis
Novel gel electrophoresis method for MS-based quantification of protein biomarkers
Noninvasive biomarker for Parkinson’s disease possibly found in EEG data
Promise of liquid biopsy in cancer biomarker detection and prenatal screening
Compound improves heart failure biomarker even after hospitalization
Researchers find TNF cannot be used as a biomarker for RA treatment discontinuation